Immunohistochemical Detections of EGFR Mutations in NSCLC
In recent years, it has been well known that non-small cell lung cancer (NSCLC) patients with mutations of epidermal growth factor receptor (EGFR) response better to EGFR-tyrosine kinase inhibitor treatment. Although DNA-based assays (e.g. DNA sequencing) are the most frequently used and a relativel...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Chinês |
| Publicat: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2014-09-01
|
| Col·lecció: | Chinese Journal of Lung Cancer |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.3779/j.issn.1009-3419.2014.09.11 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|